Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis

NCT03618784 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kang Stem Biotech Co., Ltd.